Ipsen to buy liver disease drugmaker for $952M

Ipsen is set to acquire Albireo Pharma Inc., the rare liver disease-focused biopharma spun out of AstraZeneca in 2008, for about $952 million.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news